Table of Contents
ISRN Neurology
Volume 2011 (2011), Article ID 867503, 6 pages
http://dx.doi.org/10.5402/2011/867503
Review Article

Focal Epilepsy Associated with Glioneuronal Tumors

Department of Paediatrics, University of Chieti, 66100 Chieti, Italy

Received 28 March 2011; Accepted 19 May 2011

Academic Editors: D. E. Bulman, D. T. Dexter, and R. Yamanaka

Copyright © 2011 Giulia Loiacono et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Aronica, S. Leenstra, C. W. van Veelen et al., “Glioneuronal tumors and medically intractable epilepsy: a clinical study with long-term follow-up of seizure outcome after surgery,” Epilepsy Research, vol. 43, no. 3, pp. 179–191, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. I. Blümcke and O. D. Wiestler, “Gangliogliomas: an intriguing tumor entity associated with focal epilepsies,” Journal of Neuropathology and Experimental Neurology, vol. 61, no. 7, pp. 575–584, 2002. View at Google Scholar
  3. P. Pytel and R. V. Lukas, “Update on diagnostic practice: tumors of the nervous system,” Archives of Pathology and Laboratory Medicine, vol. 133, no. 7, pp. 1062–1077, 2009. View at Google Scholar · View at Scopus
  4. M. A. Nolan, R. Sakuta, N. Chuang et al., “Dysembryoplastic neuroepithelial tumors in childhood: long-term outcome and prognostic features,” Neurology, vol. 62, no. 12, pp. 2270–2276, 2004. View at Google Scholar · View at Scopus
  5. S. H. Im, C. K. Chung, B. K. Cho, and S. K. Lee, “Supratentorial ganglioglioma and epilepsy: postoperative seizure outcome,” Journal of Neuro-Oncology, vol. 57, no. 1, pp. 59–66, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. N. R. Kim, K. C. Wang, J. S. Bang et al., “Glioblastomatous transformation of ganglioglioma: case report with reference to molecular genetic and flow cytometric analysis,” Pathology International, vol. 53, no. 12, pp. 874–882, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. F. F. Lang, F. J. Epstein, J. Ransohoff et al., “Central nervous system gangliogliomas. Part 2: clinical outcome,” Journal of Neurosurgery, vol. 79, no. 6, pp. 867–873, 1993. View at Google Scholar · View at Scopus
  8. E. Aronica, J. A. Gorter, G. H. Jansen, S. Leenstra, B. Yankaya, and D. Troost, “Expression of connexin 43 and connexin 32 gap-junction proteins in epilepsy-associated brain tumors and in the perilesional epileptic cortex,” Acta Neuropathologica, vol. 101, no. 5, pp. 449–459, 2001. View at Google Scholar · View at Scopus
  9. L. Tassi, N. Colombo, R. Garbelli et al., “Focal cortical dysplasia: neuropathological subtypes, EEG, neuroimaging and surgical outcome,” Brain, vol. 125, no. 8, pp. 1719–1732, 2002. View at Google Scholar · View at Scopus
  10. H. L. Weiner, C. Carlson, E. B. Ridgway et al., “Epilepsy surgery in young children with tuberous sclerosis: results of a novel approach,” Pediatrics, vol. 117, no. 5, pp. 1494–1502, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. M. Wong, “Mechanisms of epileptogenesis in tuberous sclerosis complex and related malformations of cortical development with abnormal glioneuronal proliferation,” Epilepsia, vol. 49, no. 1, pp. 8–21, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. M. F. Shamji, E. C. Fric-Shamji, and B. G. Benoit, “Brain tumors and epilepsy: pathophysiology of peritumoral changes,” Neurosurgical Review, vol. 32, no. 3, pp. 274–284, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. I. Najm, Z. Ying, T. Babb et al., “Mechanisms of epileptogenicity in cortical dysplasias,” Neurology, vol. 62, no. 6, supplement 3, pp. S9–S13, 2004. View at Google Scholar · View at Scopus
  14. M. Thom, “Recent advances in the neuropathology of focal lesions in epilepsy,” Expert Review of Neurotherapeutics, vol. 4, no. 6, pp. 973–984, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. E. Aronica, F. Özbas-Gerčeker, S. Redeker et al., “Expression and cellular distribution of high- and low-affinity neurotrophin receptors in malformations of cortical development,” Acta Neuropathologica, vol. 108, no. 5, pp. 422–434, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. T. Ravizza, K. Boer, S. Redeker et al., “The IL-1β system in epilepsy-associated malformations of cortical development,” Neurobiology of Disease, vol. 24, no. 1, pp. 128–143, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. A. Vezzani and T. Granata, “Brain inflammation in epilepsy: experimental and clinical evidence,” Epilepsia, vol. 46, no. 11, pp. 1724–1743, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. A. Vezzani, D. Moneta, C. Richichi, C. Perego, and M. G. De Simoni, “Functional role of proinflammatory and anti-inflammatory cytokines in seizures,” Advances in Experimental Medicine and Biology, vol. 548, pp. 123–133, 2004. View at Google Scholar · View at Scopus
  19. A. Vezzani, M. Conti, A. De Luigi et al., “Interleukin-1β immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures,” Journal of Neuroscience, vol. 19, no. 12, pp. 5054–5065, 1999. View at Google Scholar · View at Scopus
  20. T. Ravizza and A. Vezzani, “Status epilepticus induces time-dependent neuronal and astrocytic expression of interleukin-1 receptor type I in the rat limbic system,” Neuroscience, vol. 137, no. 1, pp. 301–308, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. J. G. Heida and Q. J. Pittman, “Causal links between brain cytokines and experimental febrile convulsions in the rat,” Epilepsia, vol. 46, no. 12, pp. 1906–1913, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. E. Aronica, J. A. Gorter, S. Redeker et al., “Distribution, characterization and clinical significance of microglia in glioneuronal tumours from patients with chronic intractable epilepsy,” Neuropathology and Applied Neurobiology, vol. 31, no. 3, pp. 280–291, 2005. View at Publisher · View at Google Scholar · View at PubMed
  23. K. Boer, W. G. Spliet, P. C. van Rijen, S. Redeker, D. Troost, and E. Aronica, “Evidence of activated microglia in focal cortical dysplasia,” Journal of Neuroimmunology, vol. 173, no. 1-2, pp. 188–195, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. N. C. Tan, J. C. Mulley, and S. F. Berkovic, “Genetic association studies in epilepsy: "the truth is out there",” Epilepsia, vol. 45, no. 11, pp. 1429–1442, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. E. Aronica, B. Yankaya, G. H. Jansen et al., “Ionotropic and metabotropic glutamate receptor protein expression in glioneuronal tumours from patients with intractable epilepsy,” Neuropathology and Applied Neurobiology, vol. 27, no. 3, pp. 223–237, 2001. View at Publisher · View at Google Scholar
  26. M. Avoli, J. Louvel, R. Pumain, and R. Köhling, “Cellular and molecular mechanisms of epilepsy in the human brain,” Progress in Neurobiology, vol. 77, no. 3, pp. 166–200, 2005. View at Publisher · View at Google Scholar · View at PubMed
  27. M. E. Calcagnotto, M. F. Paredes, T. Tihan, N. M. Barbaro, and S. C. Baraban, “Dysfunction of synaptic inhibition in epilepsy associated with focal cortical dysplasia,” Journal of Neuroscience, vol. 25, no. 42, pp. 9649–9657, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. R. Spreafico, L. Tassi, N. Colombo et al., “Inhibitory circuits in human dysplastic tissue,” Epilepsia, vol. 41, supplement 6, pp. S168–S173, 2000. View at Google Scholar · View at Scopus
  29. C. Cepeda, V. M. André, J. Flores-Hernández et al., “Pediatric cortical dysplasia: correlations between neuroimaging, electrophysiology and location of cytomegalic neurons and balloon cells and glutamate/GABA synaptic circuits,” Developmental Neuroscience, vol. 27, no. 1, pp. 59–76, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. M. D'Antuono, J. Louvel, R. Köhling et al., “GABAA receptor-dependent synchronization leads to ictogenesis in the human dysplastic cortex,” Brain, vol. 127, no. 7, pp. 1626–1640, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. E. Aronica, S. Redeker, K. Boer et al., “Inhibitory networks in epilepsy-associated gangliogliomas and in the perilesional epileptic cortex,” Epilepsy Research, vol. 74, no. 1, pp. 33–44, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. I. Blümcke, M. Löbach, H. K. Wolf, and O. D. Wiestler, “Evidence for developmental precursor lesions in epilepsy-associated glioneuronal tumors,” Microscopy Research and Technique, vol. 46, no. 1, pp. 53–58, 1999. View at Publisher · View at Google Scholar
  33. C. R. Miller and A. Perry, “CD34 and MAP2 immunohistochemistry in the differential diagnosis in the diagnosis of epilepsy associated glioneuronal tumors,” Advances in Anatomic Pathology, vol. 11, no. 6, pp. 326–327, 2004. View at Google Scholar
  34. I. Blümcke, K. Giencke, E. Wardelmann et al., “The CD34 epitope is expressed in neoplastic and malformative lesions associated with chronic, focal epilepsies,” Acta Neuropathologica, vol. 97, no. 5, pp. 481–490, 1999. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Lin, E. Finger, and J. C. Gutierrez-Ramos, “Expression of CD34 in endothelial cells, hematopoietic progenitors and nervous cells in fetal and adult mouse tissues,” European Journal of Immunology, vol. 25, no. 6, pp. 1508–1516, 1995. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. D. R. Sutherland, A. K. Stewart, and A. Keating, “CD34 antigen: molecular features and potential clinical applications,” Stem Cells, vol. 11, no. 3, pp. 50–57, 1993. View at Google Scholar · View at Scopus
  37. M. Asheuer, F. Pflumio, S. Benhamida et al., “Human CD34+ cells differentiate into microglia and express recombinant therapeutic protein,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 10, pp. 3557–3562, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. P. Deb, M. C. Sharma, M. Tripathi, P. Sarat Chandra, A. Gupta, and C. Sarkar, “Expression of CD34 as a novel marker for glioneuronal lesions associated with chronic intractable epilepsy,” Neuropathology and Applied Neurobiology, vol. 32, no. 5, pp. 461–468, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. M. Baybis, J. Yu, A. Lee et al., “mTOR cascade activation distinguishes tubers from focal cortical dysplasia,” Annals of Neurology, vol. 56, no. 4, pp. 478–487, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. H. Miyata, A. C. Chiang, and H. V. Vinters, “Insulin signaling pathways in cortical dysplasia and TSC-tubers: tissue microarray analysis,” Annals of Neurology, vol. 56, no. 4, pp. 510–519, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. M. van Slegtenhorst, M. Nellist, B. Nagelkerken et al., “Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products,” Human Molecular Genetics, vol. 7, no. 6, pp. 1053–1057, 1998. View at Publisher · View at Google Scholar · View at Scopus
  42. D. J. Kwiatkowski, “Tuberous sclerosis: from tubers to mTOR,” Annals of Human Genetics, vol. 67, no. 1, pp. 87–96, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Nellist, B. Verhaaf, M. A. Goedbloed, A. J. J. Reuser, A. M. W. van den Ouweland, and D. J. J. Halley, “TSC2 missense mutations inhibit tuberin phosphorylation and prevent formation of the tuberin-hamartin complex,” Human Molecular Genetics, vol. 10, no. 25, pp. 2889–2898, 2001. View at Google Scholar · View at Scopus
  44. V. Schick, M. Majores, A. Koch et al., “Alterations of phosphatidylinositol 3-kinase pathway components in epilepsy-associated glioneuronal lesions,” Epilepsia, vol. 48, no. 5, pp. 65–73, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. J. Fassunke, M. Majores, A. Tresch et al., “Array analysis of epilepsy-associated gangliogliomas reveals expression patterns related to aberrant development of neuronal precursors,” Brain, vol. 131, no. 11, pp. 3034–3050, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. D. Collen, “The plasminogen (fibrinolytic) system,” Thrombosis and Haemostasis, vol. 82, no. 2, pp. 259–270, 1999. View at Google Scholar · View at Scopus
  47. D. Alfano, P. Franco, I. Vocca et al., “The urokinase plasminogen activator and its receptor. Role in cell growth and apoptosis,” Thrombosis and Haemostasis, vol. 93, no. 2, pp. 205–211, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. E. E. Benarroch, “Tissue plasminogen activator: beyond thrombolysis,” Neurology, vol. 69, no. 8, pp. 799–802, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  49. R. Pawlak and S. Strickland, “Tissue plasminogen activator and seizures: a clot-buster's secret life,” Journal of Clinical Investigation, vol. 109, no. 12, pp. 1529–1531, 2002. View at Publisher · View at Google Scholar · View at Scopus
  50. L. Lahtinen, K. Lukasiuk, and A. Pitkänen, “Increased expression and activity of urokinase-type plasminogen activator during epileptogenesis,” European Journal of Neuroscience, vol. 24, no. 7, pp. 1935–1945, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  51. A. M. Iyer, E. Zurolo, K. Boer et al., “Tissue plasminogen activator and urokinase plasminogen activator in human epileptogenic pathologies,” Neuroscience, vol. 167, no. 3, pp. 929–945, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  52. M. Del Rosso, G. Fibbi, M. Pucci, F. Margheri, and S. Serrati, “The plasminogen activation system in inflammation,” Frontiers in Bioscience, vol. 13, no. 12, pp. 4667–4686, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. E. Oby and D. Janigro, “The blood-brain barrier and epilepsy,” Epilepsia, vol. 47, no. 11, pp. 1761–1774, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  54. A. Dityatev and T. Fellin, “Extracellular matrix in plasticity and epileptogenesis,” Neuron Glia Biology, vol. 4, no. 3, pp. 235–247, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  55. E. Aronica, J. A. Gorter, G. H. Jansen et al., “Expression and cellular distribution of multidrug transporter proteins in two major causes of medically intractable epilepsy: focal cortical dysplasia and glioneuronal tumors,” Neuroscience, vol. 118, no. 2, pp. 417–429, 2003. View at Publisher · View at Google Scholar · View at Scopus
  56. H. Potschka and W. Löscher, “Multidrug resistance-associated protein is involved in the regulation of extracellular levels of phenytoin in the brain,” NeuroReport, vol. 12, no. 11, pp. 2387–2389, 2001. View at Google Scholar · View at Scopus
  57. M. Rizzi, S. Caccia, G. Guiso et al., “Limbic seizures induce P-glycoprotein in rodent brain: functional implications for pharmacoresistance,” Journal of Neuroscience, vol. 22, no. 14, pp. 5833–5839, 2002. View at Google Scholar · View at Scopus
  58. T. Litman, T. E. Druley, W. D. Stein, and S. E. Bates, “From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance,” Cellular and Molecular Life Sciences, vol. 58, no. 7, pp. 931–959, 2001. View at Google Scholar · View at Scopus
  59. H. Clusmann, T. Kral, U. Gleissner et al., “Analysis of different types of resection for pediatric patients with temporal lobe epilepsy,” Neurosurgery, vol. 54, no. 4, pp. 847–860, 2004. View at Google Scholar · View at Scopus
  60. C. S. Rumana and A. B. Valadka, “Radiation therapy and malignant degeneration of benign supratentorial gangliogliomas,” Neurosurgery, vol. 42, no. 5, pp. 1038–1043, 1998. View at Publisher · View at Google Scholar · View at Scopus
  61. S. K. Kim, K. C. Wang, Y. S. Hwang, K. J. Kim, and B. K. Cho, “Intractable epilepsy associated with brain tumors in children: surgical modality and outcome,” Child's Nervous System, vol. 17, no. 8, pp. 445–452, 2001. View at Publisher · View at Google Scholar · View at Scopus
  62. A. Iannelli, F. Guzzetta, D. Battaglia, L. Iuvone, and C. Di Rocco, “Surgical treatment of temporal tumors associated with epilepsy in children,” Pediatric Neurosurgery, vol. 32, no. 5, pp. 248–254, 2000. View at Google Scholar · View at Scopus
  63. J. H. Johnson Jr., S. Hariharan, J. Berman et al., “Clinical outcome of pediatric gangliogliomas: ninety-nine cases over 20 years,” Pediatric Neurosurgery, vol. 27, no. 4, pp. 203–207, 1997. View at Google Scholar · View at Scopus
  64. D. B. Sinclair, M. Wheatley, K. Aronyk et al., “Pathology and neuroimaging in pediatric temporal lobectomy for intractable epilepsy,” Pediatric Neurosurgery, vol. 35, no. 5, pp. 239–246, 2001. View at Publisher · View at Google Scholar · View at Scopus
  65. C. Luyken, I. Blümcke, R. Fimmers et al., “The spectrum of long-term epilepsy-associated tumors: long-term seizure and tumor outcome and neurosurgical aspects,” Epilepsia, vol. 44, no. 6, pp. 822–830, 2003. View at Publisher · View at Google Scholar · View at Scopus
  66. M. Giulioni, E. Galassi, M. Zucchelli, and L. Volpi, “Seizure outcome of lesionectomy in glioneuronal tumors associated with epilepsy in children,” Journal of Neurosurgery, vol. 102, no. 3, pp. 288–293, 2005. View at Google Scholar · View at Scopus
  67. I. Yang, E. F. Chang, S. J. Han et al., “Early surgical intervention in adult patients with ganglioglioma is associated with improved clinical seizure outcomes,” Journal of Clinical Neuroscience, vol. 18, no. 1, pp. 29–33, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  68. D. N. Franz, J. Leonard, C. Tudor et al., “Rapamycin causes regression of astrocytomas in tuberous sclerosis complex,” Annals of Neurology, vol. 59, no. 3, pp. 490–498, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus